Royalty Pharma plc (RPRX)
USD 29.97
(-3.66%)
USD 29.97
(-3.66%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.13 Billion USD | 2549.5% |
| 2022 | 42.83 Million USD | -91.05% |
| 2021 | 478.75 Million USD | -3.32% |
| 2020 | 495.19 Million USD | -78.91% |
| 2019 | 2.34 Billion USD | 70.46% |
| 2018 | 1.37 Billion USD | 13.86% |
| 2017 | 1.21 Billion USD | 113.82% |
| 2016 | 565.9 Million USD | -2.67% |
| 2015 | 581.42 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 4.77 Million USD | -99.03% |
| 2024 Q2 | 102 Million USD | 2034.87% |
| 2023 Q1 | 340.75 Million USD | 155.85% |
| 2023 Q4 | 494.34 Million USD | 585.5% |
| 2023 Q2 | 227.62 Million USD | -33.2% |
| 2023 FY | 1.13 Billion USD | 2549.5% |
| 2023 Q3 | 72.11 Million USD | -68.32% |
| 2022 FY | 42.83 Million USD | -91.05% |
| 2022 Q4 | -610.16 Million USD | -380.11% |
| 2022 Q3 | 217.83 Million USD | -28.46% |
| 2022 Q2 | 304.5 Million USD | 863.67% |
| 2022 Q1 | -39.87 Million USD | -604.48% |
| 2021 Q3 | 101.92 Million USD | -76.88% |
| 2021 Q4 | 7.9 Million USD | -92.25% |
| 2021 Q1 | 69.11 Million USD | -59.58% |
| 2021 FY | 478.75 Million USD | -3.32% |
| 2021 Q2 | 440.77 Million USD | 537.71% |
| 2020 Q3 | 291 Million USD | -34.17% |
| 2020 Q1 | 71.24 Million USD | -94.98% |
| 2020 FY | 495.19 Million USD | -78.91% |
| 2020 Q4 | 171 Million USD | -41.24% |
| 2020 Q2 | 442.07 Million USD | 520.54% |
| 2019 Q1 | 367.44 Million USD | 0.0% |
| 2019 FY | 2.34 Billion USD | 70.46% |
| 2019 Q4 | 1.42 Billion USD | 247.3% |
| 2019 Q3 | 408.98 Million USD | 169.58% |
| 2019 Q2 | 151.71 Million USD | -58.71% |
| 2018 FY | 1.37 Billion USD | 13.86% |
| 2017 FY | 1.21 Billion USD | 113.82% |
| 2016 FY | 565.9 Million USD | -2.67% |
| 2015 FY | 581.42 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | 875.17% |
| Alkermes plc | 355.75 Million USD | -218.991% |
| Agenus Inc. | -245.76 Million USD | 561.763% |
| Aptorum Group Limited | -2.82 Million USD | 40276.135% |
| Ardelyx, Inc. | -66.06 Million USD | 1817.702% |
| Dyadic International, Inc. | -6.79 Million USD | 16799.882% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | 121342.949% |
| Lantern Pharma Inc. | -15.96 Million USD | 7209.805% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | 6063.745% |
| Novavax, Inc. | -545.06 Million USD | 308.203% |
| Janux Therapeutics, Inc. | -58.29 Million USD | 2046.776% |
| Pyxis Oncology, Inc. | -73.79 Million USD | 1637.924% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | 6218.992% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | 11464.25% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | 2024.013% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 403.732% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | 4762.56% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | 3139.191% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | 789.558% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | 1647.213% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 5692.795% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | 1922.88% |
| Clearside Biomedical, Inc. | -32.48 Million USD | 3593.409% |
| C4 Therapeutics, Inc. | -132.49 Million USD | 956.524% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 357.775% |
| AlloVir, Inc. | -190.41 Million USD | 695.97% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | 652.836% |
| VYNE Therapeutics Inc. | -28.45 Million USD | 4088.591% |
| Bicycle Therapeutics plc | -180.66 Million USD | 728.146% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | 733.798% |
| ChromaDex Corporation | -4.93 Million USD | 23081.652% |
| Chimerix, Inc. | -82.09 Million USD | 1482.342% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | 2644.282% |
| Caribou Biosciences, Inc. | -102.07 Million USD | 1211.819% |
| CRISPR Therapeutics AG | -153.61 Million USD | 838.776% |
| Precision BioSciences, Inc. | -61.31 Million USD | 1950.705% |
| Fate Therapeutics, Inc. | -160.92 Million USD | 805.181% |
| Fortress Biotech, Inc. | -60.63 Million USD | 1971.521% |
| Fortress Biotech, Inc. | -60.63 Million USD | 1971.521% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | 1491.069% |
| ImmuCell Corporation | -5.77 Million USD | 19752.173% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | 1104.625% |
| Immix Biopharma, Inc. | -15.42 Million USD | 7456.609% |
| Incyte Corporation | 597.59 Million USD | -89.899% |
| Innoviva, Inc. | 179.72 Million USD | -531.439% |
| IO Biotech, Inc. | -86.08 Million USD | 1418.302% |
| Jaguar Health, Inc. | -41.3 Million USD | 2847.782% |
| Keros Therapeutics, Inc. | -152.99 Million USD | 841.76% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | -2075.929% |
| ContextLogic Inc. | -317 Million USD | 457.992% |
| MiMedx Group, Inc. | 67.43 Million USD | -1582.756% |
| MEI Pharma, Inc. | 17.77 Million USD | -6283.361% |
| NextCure, Inc. | -62.72 Million USD | 1909.279% |
| Onconetix, Inc. | -37.4 Million USD | 3133.529% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | 2974.526% |
| Opthea Limited | -220.24 Million USD | 615.267% |
| Psyence Biomedical Ltd. | -51.15 Million USD | 2318.247% |
| Vaxcyte, Inc. | -402.26 Million USD | 382.11% |
| PDS Biotechnology Corporation | -42.94 Million USD | 2742.701% |
| Precigen, Inc. | -95.9 Million USD | 1283.302% |
| Pharming Group N.V. | -10.54 Million USD | 10858.76% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | 662.936% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | 4723.86% |
| PureTech Health plc | -65.69 Million USD | 1827.376% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | 4622.873% |
| Avidity Biosciences, Inc. | -212.22 Million USD | 634.744% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | 4762.56% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 540.146% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | 4266.363% |
| Acelyrin, Inc. | -381.64 Million USD | 397.356% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | 9047872.049% |
| Summit Therapeutics Inc. | -614.92 Million USD | 284.547% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | 3427.861% |
| Senti Biosciences, Inc. | -92.91 Million USD | 1321.315% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | 1183.901% |
| Elevation Oncology, Inc. | -45.7 Million USD | 2583.008% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | 3329.465% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | 8781.501% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | 17075.826% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | 3964.975% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | 13449.418% |
| Wave Life Sciences Ltd. | -57.51 Million USD | 2073.178% |
| Seer, Inc. | -86.27 Million USD | 1415.338% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | 1793.909% |
| Aadi Bioscience, Inc. | -65.76 Million USD | 1825.59% |
| ESSA Pharma Inc. | -26.58 Million USD | 4369.127% |
| GlycoMimetics, Inc. | -36.89 Million USD | 3175.479% |
| GT Biopharma, Inc. | -7.59 Million USD | 15037.923% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 570.181% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | 2285.525% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | -1489.181% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | 2185.249% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | 2410.33% |
| Alzamend Neuro, Inc. | -9.94 Million USD | 11507.951% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 298.106% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | 31728.595% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | 2322.637% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 562.075% |
| Aptose Biosciences Inc. | -51.2 Million USD | 2316.17% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | 1254.484% |
| Soligenix, Inc. | -6.14 Million USD | 18580.441% |
| Century Therapeutics, Inc. | -136.67 Million USD | 930.328% |
| Kura Oncology, Inc. | -152.63 Million USD | 843.515% |
| TScan Therapeutics, Inc. | -89.21 Million USD | 1371.979% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | 10868.969% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | -200588.631% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | 199543.585% |
| Autolus Therapeutics plc | -208.38 Million USD | 644.59% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | 1678.394% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | 1702.986% |
| Eterna Therapeutics Inc. | -21.66 Million USD | 5337.373% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | 603.811% |
| GRI Bio, Inc. | -13.03 Million USD | 8804.717% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | 27547.396% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | 1014.569% |
| IGM Biosciences, Inc. | -246.41 Million USD | 560.536% |
| INmune Bio, Inc. | -30 Million USD | 3881.772% |
| Heron Therapeutics, Inc. | -110.55 Million USD | 1126.451% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | 2789.576% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | 7209.75% |
| Entero Therapeutics, Inc. | -15.79 Million USD | 7284.775% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | 2001.372% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | 1221.743% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 510.984% |
| Coherus BioSciences, Inc. | -237.89 Million USD | 577.037% |
| Verastem, Inc. | -87.36 Million USD | 1398.928% |
| Abeona Therapeutics Inc. | -54.18 Million USD | 2194.253% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | 803.398% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | 1072.787% |
| Histogen Inc. | -10.62 Million USD | 10784.813% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | 8043.259% |
| Surrozen, Inc. | -43.04 Million USD | 2736.574% |
| Organovo Holdings, Inc. | -14.67 Million USD | 7835.219% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | 22408.385% |
| Ovid Therapeutics Inc. | -52.33 Million USD | 2268.24% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | 4592.079% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | 4312.763% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | 13679.303% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | 851.123% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | 2419.489% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | 3917.776% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | 10993.322% |
| Apollomics, Inc. | -172.6 Million USD | 757.49% |
| Amarin Corporation plc | -59.11 Million USD | 2019.803% |
| Mesoblast Limited | -87.95 Million USD | 1390.229% |
| Turnstone Biologics Corp. | -55.2 Million USD | 2155.859% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | 872.196% |
| Synaptogenix, Inc. | -6.03 Million USD | 18893.297% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | 7101.691% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | 1554.542% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 23784.484% |
| Monopar Therapeutics Inc. | -8.4 Million USD | 13606.398% |
| Exelixis, Inc. | 207.76 Million USD | -446.21% |
| Better Therapeutics, Inc. | -39.76 Million USD | 2954.21% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | 888.364% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 314.675% |
| NLS Pharmaceutics AG | -12.17 Million USD | 9423.294% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | 14659.065% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | 3790.637% |
| Gritstone bio, Inc. | -138.49 Million USD | 919.434% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | 1860.388% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | 28471.205% |
| Avid Bioservices, Inc. | -140.75 Million USD | 906.259% |
| Insmed Incorporated | -749.56 Million USD | 251.399% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | 7571.17% |
| MediWound Ltd. | -6.71 Million USD | 16997.469% |
| OmniAb, Inc. | -50.61 Million USD | 2341.913% |
| Alector, Inc. | -130.39 Million USD | 970.332% |
| Seres Therapeutics, Inc. | -113.72 Million USD | 1097.884% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | 2288.813% |
| Zai Lab Limited | -334.62 Million USD | 439.141% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 450.273% |
| Aura Biosciences, Inc. | -76.4 Million USD | 1585.229% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | 583.665% |
| Immunic, Inc. | -93.61 Million USD | 1312.274% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | 935.094% |
| Veracyte, Inc. | -74.4 Million USD | 1625.233% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | 14885.051% |
| FibroGen, Inc. | -284.23 Million USD | 499.263% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | 4426.144% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | 16307.538% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | 6125.872% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | -173.565% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | 5131.408% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | -2203.249% |
| TG Therapeutics, Inc. | 12.67 Million USD | -8855.445% |
| Galecto, Inc. | -38.34 Million USD | 3059.227% |
| Calithera Biosciences, Inc. | -18.86 Million USD | 6115.234% |
| Fortrea Holdings Inc. | -3.4 Million USD | 33477.471% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | 996.082% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | 6617.914% |
| XBiotech Inc. | -24.55 Million USD | 4721.224% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | 1860.388% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | 1910.52% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | 1252.982% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | 5396.28% |
| Theravance Biopharma, Inc. | -55.19 Million USD | 2156.119% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 287.069% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | 1762.639% |
| Vaxxinity, Inc. | -56.93 Thousand USD | 1993344.81% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | 600.944% |
| Gain Therapeutics, Inc. | -22.26 Million USD | 5196.365% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | 616.514% |
| NexImmune, Inc. | -32.34 Million USD | 3608.596% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | 21566.341% |
| Marker Therapeutics, Inc. | -14.04 Million USD | 8179.471% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 71.296% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | 4785.331% |
| Scopus BioPharma Inc. | -11.6 Million USD | 9874.771% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | 1071.621% |
| Ainos, Inc. | -13.77 Million USD | 8341.022% |
| Pluri Inc. | -20.88 Million USD | 5532.947% |
| Prothena Corporation plc | -147.02 Million USD | 871.849% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | 1096.596% |
| Celularity Inc. | -196.29 Million USD | 678.127% |
| Rallybio Corporation | -74.56 Million USD | 1621.96% |
| Cue Biopharma, Inc. | -50.73 Million USD | 2336.875% |
| MeiraGTx Holdings plc | -84.02 Million USD | 1450.559% |
| Omeros Corporation | -117.81 Million USD | 1063.25% |
| Humacyte, Inc. | -110.77 Million USD | 1124.44% |
| Immunocore Holdings plc | -55.28 Million USD | 2152.624% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | 6410.242% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | 5048.908% |
| Blueprint Medicines Corporation | -506.98 Million USD | 323.84% |
| CalciMedica, Inc. | -34.35 Million USD | 3403.065% |
| Cabaletta Bio, Inc. | -67.67 Million USD | 1776.888% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | 902.542% |
| Scholar Rock Holding Corporation | -165.78 Million USD | 784.505% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 500.64% |
| Pulmatrix, Inc. | -14.12 Million USD | 8136.499% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | 3324.418% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | 1473.259% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 335.838% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | 1182.124% |
| Cytokinetics, Incorporated | -526.24 Million USD | 315.648% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | 3246.635% |
| Nutriband Inc. | -5.48 Million USD | 20788.588% |
| Protara Therapeutics, Inc. | -40.42 Million USD | 2907.605% |
| Vor Biopharma Inc. | -117.86 Million USD | 1062.842% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 73.905% |
| Evogene Ltd. | -23.87 Million USD | 4852.435% |
| ProKidney Corp. | -35.46 Million USD | 3299.6% |
| Applied Therapeutics, Inc. | -119.76 Million USD | 1047.566% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | 14564.979% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 276.435% |
| CorMedix Inc. | -46.33 Million USD | 2548.971% |
| BioLineRx Ltd. | -60.61 Million USD | 1972.231% |
| Tango Therapeutics, Inc. | -101.74 Million USD | 1215.382% |
| Galectin Therapeutics Inc. | -41.06 Million USD | 2863.439% |
| Atai Life Sciences N.V. | -40.22 Million USD | 2921.286% |
| Renovaro Biosciences Inc. | -80.65 Million USD | 1507.107% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | 1602.673% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 488.388% |
| Sagimet Biosciences Inc. | -27.87 Million USD | 4171.007% |
| MediciNova, Inc. | -8.57 Million USD | 13339.595% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | 1020.556% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | 13647.29% |
| GeoVax Labs, Inc. | -25.96 Million USD | 4470.333% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 574.354% |
| Biomea Fusion, Inc. | -117.25 Million USD | 1067.834% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 281.109% |
| Mereo BioPharma Group plc | -29.46 Million USD | 3951.334% |
| Cullinan Oncology, Inc. | -153.16 Million USD | 840.937% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | 642.049% |
| Absci Corporation | -110.56 Million USD | 1126.386% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | 3863.96% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | 1225.414% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | 580.99% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | -7957.611% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | 688.113% |
| Allakos Inc. | -185.7 Million USD | 711.108% |
| Imunon, Inc. | -19.51 Million USD | 5915.195% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | 1265.905% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | -969.186% |
| BioAtla, Inc. | -123.46 Million USD | 1019.177% |
| NLS Pharmaceutics AG | -12.17 Million USD | 9423.294% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | 7158.303% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 446.763% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | 3171.352% |
| XOMA Corporation | -40.83 Million USD | 2879.344% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | 1214.002% |
| Cara Therapeutics, Inc. | -118.51 Million USD | 1057.561% |
| aTyr Pharma, Inc. | -50.38 Million USD | 2352.146% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | 1394.305% |
| Akero Therapeutics, Inc. | -151.75 Million USD | 847.787% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | 577.355% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | 3331.396% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | 14124.251% |
| Akari Therapeutics, Plc | -10 Million USD | 11439.269% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | 1685705.644% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | -303.004% |
| Lexaria Bioscience Corp. | -6.66 Million USD | 17127.025% |
| UroGen Pharma Ltd. | -102.24 Million USD | 1209.927% |
| Sutro Biopharma, Inc. | -106.79 Million USD | 1162.648% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | 14691.837% |
| Orgenesis Inc. | -55.36 Million USD | 2149.88% |
| Entera Bio Ltd. | -8.88 Million USD | 12866.723% |
| GH Research PLC | -35.58 Million USD | 3288.9% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | 5545.461% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | 1566.421% |
| Xencor, Inc. | -126.08 Million USD | 1000.04% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | 30236.054% |
| Replimune Group, Inc. | -215.79 Million USD | 625.888% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | 5436.243% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | -45130.53% |
| Lexaria Bioscience Corp. | -6.66 Million USD | 17127.025% |
| Portage Biotech Inc. | -75.33 Million USD | 1606.304% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | 13647.29% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | 1274.108% |
| OncoCyte Corporation | -27.78 Million USD | 4184.929% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | 8558.046% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | 10303.947% |
| Purple Biotech Ltd. | -19.88 Million USD | 5808.421% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | 16268.03% |
| scPharmaceuticals Inc. | -54.81 Million USD | 2170.487% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | 6582.491% |
| HilleVax, Inc. | -123.56 Million USD | 1018.403% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | 11328.198% |
| Tharimmune, Inc. | -9.31 Million USD | 12277.514% |
| Genprex, Inc. | -30.86 Million USD | 3777.307% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | 581.015% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | 3870.964% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | 63783.165% |
| Virios Therapeutics, Inc. | -5.29 Million USD | 21528.074% |
| OKYO Pharma Limited | -16.82 Thousand USD | 6744842.789% |
| Savara Inc. | -54.69 Million USD | 2174.727% |
| Curis, Inc. | -47.41 Million USD | 2493.508% |
| Daré Bioscience, Inc. | -30.16 Million USD | 3862.539% |
| Carmell Therapeutics Corporation | -15.44 Million USD | 7447.54% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | 20477.698% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | 3906.252% |
| BeiGene, Ltd. | -881.7 Million USD | 228.709% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | 5429.36% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 360.064% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | 1537.317% |
| Erasca, Inc. | -125.04 Million USD | 1007.562% |
| bluebird bio, Inc. | -211.91 Million USD | 635.519% |
| Protagenic Therapeutics, Inc. | -5 Million USD | 22794.424% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | -576.927% |
| DBV Technologies S.A. | -72.72 Million USD | 1660.424% |
| Protagenic Therapeutics, Inc. | -5 Million USD | 22794.424% |
| Moderna, Inc. | -4.71 Billion USD | 124.074% |
| Vincerx Pharma, Inc. | -40.15 Million USD | 2925.993% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | 20030.348% |
| Molecular Templates, Inc. | -8.12 Million USD | 14068.907% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | 1979.238% |
| Travere Therapeutics, Inc. | -111.39 Million USD | 1118.711% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | 938.432% |
| Spruce Biosciences, Inc. | -47.91 Million USD | 2468.234% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | 902.405% |
| Cogent Biosciences, Inc. | -192.41 Million USD | 689.8% |
| MacroGenics, Inc. | -9.05 Million USD | 12628.527% |
| RenovoRx, Inc. | -10.23 Million USD | 11191.028% |
| Adicet Bio, Inc. | -142.65 Million USD | 895.493% |
| Prime Medicine, Inc. | -198.13 Million USD | 672.764% |
| Aditxt, Inc. | -32.38 Million USD | 3604.647% |
| Adagene Inc. | -18.94 Million USD | 6089.717% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 15620.747% |
| Quantum-Si incorporated | -95.96 Million USD | 1282.612% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | 1053.41% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | 7884.69% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | -757.579% |
| SciSparc Ltd. | -5.12 Million USD | 22256.072% |
| Vericel Corporation | -3.18 Million USD | 35764.173% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | 943797.507% |
| Minerva Neurosciences, Inc. | -30 Million USD | 3882.105% |
| Generation Bio Co. | -126.61 Million USD | 996.308% |
| Astria Therapeutics, Inc. | -72.89 Million USD | 1656.892% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | 1476.524% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 532.911% |
| Invivyd, Inc. | -198.64 Million USD | 671.293% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 431.849% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | 13164.231% |
| Spero Therapeutics, Inc. | 22.8 Million USD | -4876.033% |
| Artelo Biosciences, Inc. | -9.87 Million USD | 11593.154% |
| 2seventy bio, Inc. | -217.57 Million USD | 621.595% |
| ADMA Biologics, Inc. | -28.23 Million USD | 4118.676% |
| Clene Inc. | -49.5 Million USD | 2392.409% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | 5191.786% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | 2395.655% |
| GeoVax Labs, Inc. | -25.96 Million USD | 4470.333% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 445.916% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | 3587.193% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | -4894.868% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | 1248.713% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | 1618.091% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | 805.721% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 284.508% |
| Evaxion Biotech A/S | -22.12 Million USD | 5229.193% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | 1505.611% |
| Verve Therapeutics, Inc. | -200.06 Million USD | 667.224% |
| Trevena, Inc. | -40.28 Million USD | 2916.734% |
| Surrozen, Inc. | -43.04 Million USD | 2736.574% |
| Tyra Biosciences, Inc. | -69.13 Million USD | 1741.499% |
| Cingulate Inc. | -23.53 Million USD | 4921.91% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | 16518.316% |
| Unity Biotechnology, Inc. | -39.86 Million USD | 2947.05% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | 14817.704% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | 1357.991% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | 1951.702% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | 2007.188% |
| Clearmind Medicine Inc. | -11.95 Million USD | 9592.522% |
| Kronos Bio, Inc. | -112.67 Million USD | 1107.192% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | 1740.005% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | 44745016.668% |
| Viking Therapeutics, Inc. | -85.89 Million USD | 1421.187% |
| Statera Biopharma, Inc. | -174.4 Million USD | 750.677% |
| ImmunityBio, Inc. | -583.19 Million USD | 294.589% |
| Korro Bio, Inc. | -81.17 Million USD | 1498.061% |
| Kineta, Inc. | -14.09 Million USD | 8149.039% |
| BioVie Inc. | -32.12 Million USD | 3633.048% |
| Codexis, Inc. | -76.24 Million USD | 1588.502% |
| Celularity Inc. | -196.29 Million USD | 678.127% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | 628.989% |
| Celcuity Inc. | -63.77 Million USD | 1879.319% |
| Virax Biolabs Group Limited | -6.73 Million USD | 16953.461% |
| Cibus, Inc. | -267.62 Million USD | 524.036% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | 2914.15% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | 3268.954% |
| IN8bio, Inc. | -30 Million USD | 3881.898% |
| Kodiak Sciences Inc. | -260.49 Million USD | 535.652% |
| Annexon, Inc. | -134.23 Million USD | 945.396% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | 1068.578% |
| Assembly Biosciences, Inc. | -61.22 Million USD | 1953.456% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | 3697.622% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 409.822% |
| Eyenovia, Inc. | -27.26 Million USD | 4262.833% |
| Puma Biotechnology, Inc. | 21.59 Million USD | -5156.051% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | 212218.505% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | 1585.307% |
| Arcellx, Inc. | -70.69 Million USD | 1705.367% |
| Cardiff Oncology, Inc. | -41.44 Million USD | 2838.433% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | 948.056% |
| Regulus Therapeutics Inc. | -30.03 Million USD | 3878.12% |
| Moolec Science SA | -51.78 Million USD | 2291.27% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | 2266.913% |
| Geron Corporation | -184.12 Million USD | 716.332% |
| LAVA Therapeutics N.V. | -41.97 Million USD | 2803.659% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | 934.707% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | 12862.698% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | 5442.097% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | 761.056% |
| Humacyte, Inc. | -110.77 Million USD | 1124.44% |
| Structure Therapeutics Inc. | -89.62 Million USD | 1366.273% |
| 89bio, Inc. | -142.18 Million USD | 898.117% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | 1745.641% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | 11036.051% |
| Genelux Corporation | -28.29 Million USD | 4110.439% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | 4004.469% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | 740.718% |
| Notable Labs, Ltd. | -11.26 Million USD | 10174.876% |
| Liquidia Corporation | -78.5 Million USD | 1545.612% |
| Mustang Bio, Inc. | -51.6 Million USD | 2299.205% |
| Immunovant, Inc. | -259.33 Million USD | 537.592% |
| Quantum-Si incorporated | -95.96 Million USD | 1282.612% |
| Arbutus Biopharma Corporation | -72.84 Million USD | 1657.789% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | 5955.394% |
| Vera Therapeutics, Inc. | -95.99 Million USD | 1282.242% |
| Acasti Pharma Inc. | -12.85 Million USD | 8929.332% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | 5153.171% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | 7209.75% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | 722.192% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | 26482.181% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | 9200.513% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | 3948.069% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | 3010.726% |
| PepGen Inc. | -78.62 Million USD | 1543.332% |
| Moleculin Biotech, Inc. | -29.76 Million USD | 3912.133% |
| United Therapeutics Corporation | 984.8 Million USD | -15.235% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | 5198.086% |
| Solid Biosciences Inc. | -96.01 Million USD | 1281.934% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 23784.484% |
| Immuneering Corporation | -53.47 Million USD | 2222.311% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | 22408.385% |
| Silo Pharma, Inc. | -3.7 Million USD | 30765.528% |
| Belite Bio, Inc | -31.63 Million USD | 3687.614% |
| XOMA Corporation | -40.83 Million USD | 2879.344% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | 2187.435% |
| Bionomics Limited | -15.49 Billion USD | 107.325% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | 1451.234% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | 3992.149% |
| uniQure N.V. | -308.47 Million USD | 467.882% |
| Cassava Sciences, Inc. | -97.21 Million USD | 1267.321% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 15620.747% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | 1019.415% |
| Forte Biosciences, Inc. | -31.47 Million USD | 3705.395% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | 13936.565% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | 4004.066% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | 212218.505% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | 4426.144% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | 6984.04% |
| Altimmune, Inc. | -88.44 Million USD | 1383.067% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | 848.65% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | 3992.149% |
| Compugen Ltd. | -18.75 Million USD | 6151.157% |
| Peak Bio, Inc. | -1259.26 USD | 90119217.577% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | 2564.405% |
| Benitec Biopharma Inc. | -21.75 Million USD | 5317.388% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 434.967% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | 1468.028% |
| Zura Bio Limited | -60.36 Million USD | 1980.109% |
| PolyPid Ltd. | -23.86 Million USD | 4855.223% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | 7313.539% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | 1468.028% |
| Instil Bio, Inc. | -156.08 Million USD | 827.052% |
| argenx SE | -295.05 Million USD | 484.62% |
| Immunome, Inc. | -106.8 Million USD | 1162.519% |
| Compass Therapeutics, Inc. | -42.49 Million USD | 2770.575% |
| Verona Pharma plc | -54.36 Million USD | 2187.281% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | 1235.777% |
| Shattuck Labs, Inc. | -87.29 Million USD | 1399.954% |
| CervoMed Inc. | -2.17 Million USD | 52351.398% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | 1010.409% |
| Plus Therapeutics, Inc. | -13.31 Million USD | 8622.334% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | 2705.519% |
| Moolec Science SA | -51.78 Million USD | 2291.27% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | 6562971.384% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | 939.888% |
| AnaptysBio, Inc. | -163.61 Million USD | 793.583% |
| Design Therapeutics, Inc. | -66.86 Million USD | 1797.278% |
| Leap Therapeutics, Inc. | -81.41 Million USD | 1493.905% |
| NeurAxis, Inc. | -14.62 Million USD | 7858.656% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | 3095.708% |
| Lumos Pharma, Inc. | -34.03 Million USD | 3434.413% |
| Achilles Therapeutics plc | -69.66 Million USD | 1728.987% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | 1235.777% |
| 180 Life Sciences Corp. | -19.93 Million USD | 5792.639% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | -37617.288% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | 44745016.668% |
| Nutriband Inc. | -5.48 Million USD | 20788.588% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | 1226.979% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | 2434.713% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | 1572.071% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | 3440.695% |
| MoonLake Immunotherapeutics | -36 Million USD | 3251.681% |
| Palisade Bio, Inc. | -12.3 Million USD | 9326.293% |
| Tourmaline Bio, Inc. | -42.12 Million USD | 2794.032% |
| Beam Therapeutics Inc. | -132.52 Million USD | 956.304% |
| Neurogene Inc. | -36.31 Million USD | 3224.801% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | 794.449% |
| AEON Biopharma, Inc. | -52.55 Million USD | 2259.285% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | 1256.259% |
| Sesen Bio, Inc. | -19.88 Million USD | 5807.272% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | 1685.318% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | 9168.591% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 355.572% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | 1117.186% |
| Athira Pharma, Inc. | -117.67 Million USD | 1064.404% |
| Vaccinex, Inc. | -20.25 Million USD | 5703.842% |
| HCW Biologics Inc. | -24.99 Million USD | 4640.375% |
| XOMA Corporation | -40.83 Million USD | 2879.344% |
| Nektar Therapeutics | -276.05 Million USD | 511.088% |
| Arvinas, Inc. | -367.3 Million USD | 408.967% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | 1685705.644% |
| Merus N.V. | -154.93 Million USD | 832.439% |
| Omega Therapeutics, Inc. | -97.42 Million USD | 1264.792% |
| Quince Therapeutics, Inc. | -31.38 Million USD | 3715.848% |
| Rezolute, Inc. | -68.45 Million USD | 1757.684% |
| Clene Inc. | -49.5 Million USD | 2392.409% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | 7457.838% |
| BeyondSpring Inc. | -21.02 Million USD | 5497.289% |
| Synlogic, Inc. | -57.28 Million USD | 2081.135% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | 9635.619% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | 10582.487% |
| Peak Bio, Inc. | -1259.26 USD | 90119217.577% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | 3136.914% |
| Krystal Biotech, Inc. | 10.93 Million USD | -10280.845% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | 893.041% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 449.068% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | 24669.011% |
| MannKind Corporation | -11.93 Million USD | 9606.065% |
| Ikena Oncology, Inc. | -68.16 Million USD | 1764.809% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | 5500.114% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | 1321.131% |
| Gossamer Bio, Inc. | -179.81 Million USD | 731.105% |
| CohBar, Inc. | -11.96 Million USD | 9586.898% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | 4500.628% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | 3863.96% |
| Legend Biotech Corporation | -518.25 Million USD | 318.973% |
| Mural Oncology plc | -207.44 Million USD | 647.048% |
| Biora Therapeutics, Inc. | -124.11 Million USD | 1014.341% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | 6304.763% |
| Disc Medicine, Inc. | -76.42 Million USD | 1584.821% |
| Champions Oncology, Inc. | -7.27 Million USD | 15696.949% |
| REGENXBIO Inc. | -263.49 Million USD | 530.687% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | 10792.793% |
| Anavex Life Sciences Corp. | -47.5 Million USD | 2488.873% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | 3087.703% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | 1232.987% |
| Vaxart, Inc. | -82.46 Million USD | 1476.14% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | -339911.925% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | 3122.797% |
| Cellectis S.A. | -101.05 Million USD | 1222.942% |
| Longeveron Inc. | -21.41 Million USD | 5399.743% |
| Repare Therapeutics Inc. | -93.79 Million USD | 1309.896% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 311.732% |
| Inozyme Pharma, Inc. | -71.16 Million USD | 1694.562% |
| Revolution Medicines, Inc. | -436.36 Million USD | 360.064% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | 17370.339% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | 3781.657% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | 1736.788% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | 1853.127% |
| Anixa Biosciences, Inc. | -9.81 Million USD | 11666.955% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 68.648% |
| Denali Therapeutics Inc. | -145.22 Million USD | 881.437% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | 943797.507% |
| Veru Inc. | -93.15 Million USD | 1318.251% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | 4298.579% |
| Cingulate Inc. | -23.53 Million USD | 4921.91% |
| Passage Bio, Inc. | -102.06 Million USD | 1211.906% |
| Context Therapeutics Inc. | -23.96 Million USD | 4835.537% |
| Exicure, Inc. | -16.91 Million USD | 6809.436% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | 700.705% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | 3105.068% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | 17539.333% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | 714.493% |
| Nuvalent, Inc. | -126.21 Million USD | 999.099% |
| ABVC BioPharma, Inc. | -10.51 Million USD | 10891.852% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | 1406.224% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | 3815.407% |
| OmniAb, Inc. | -50.61 Million USD | 2341.913% |
| Anew Medical, Inc. | 1.34 Million USD | -84203.761% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | 7172.82% |
| Lipocine Inc. | -16.35 Million USD | 7039.997% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | 1809.242% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | 1882.229% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | 2789.576% |
| G1 Therapeutics, Inc. | -47.96 Million USD | 2465.864% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | 5822.525% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 309.577% |
| Ocugen, Inc. | -63.07 Million USD | 1899.096% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | 1285.428% |
| Q32 Bio Inc. | -112.96 Million USD | 1104.625% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | 6700.942% |
| Alumis Inc. Common Stock | -154.99 Million USD | 832.184% |
| Equillium, Inc. | -13.33 Million USD | 8610.191% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | 1979.922% |
| Coya Therapeutics, Inc. | -7.98 Million USD | 14307.027% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | 6119.948% |
| Galera Therapeutics, Inc. | -59.08 Million USD | 2020.778% |
| Evelo Biosciences, Inc. | -114.52 Million USD | 1090.888% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | 6274.975% |
| Dominari Holdings Inc. | -22.88 Million USD | 5059.505% |
| Edesa Biotech, Inc. | -8.37 Million USD | 13651.203% |
| vTv Therapeutics Inc. | -20.25 Million USD | 5704.119% |
| Bio-Techne Corporation | 168.1 Million USD | -575.075% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 422.315% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | -780.72% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | 1031.474% |
| Candel Therapeutics, Inc. | -37.93 Million USD | 3091.207% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | 1107.47% |
| Nkarta, Inc. | -117.5 Million USD | 1065.808% |
| BioCardia, Inc. | -11.57 Million USD | 9907.571% |
| Iterum Therapeutics plc | -38.37 Million USD | 3057.53% |